{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-17T05:28:54.407591+00:00","published_at":"2026-10-17T04:45:33.016234+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:10bsjzq13o4ih0","event_type":"CEO_CHANGED","effective_at":"2026-04-21","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:alexander-hardy","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:16"],"evidence_ids":["alpha:projection-evidence:document:b3598f3e6eda560d83a00f9929a83cc61bd68f09f96aa5c37d826e06902d6ccf"],"summary":"Adrian Hardy executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:9f1wel1o9vnht","event_type":"CEO_CHANGED","effective_at":"2026-04-21","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:alexander-hardy-bmrn","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:17"],"evidence_ids":["alpha:projection-evidence:document:b9594a4aa6be439b3adb396114e1a37caa813bbc904fc7cc39b1525322583957"],"summary":"Alexander Hardy executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:xdm6ip16e42u9","event_type":"CFO_CHANGED","effective_at":"2026-04-21","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:brian-r-mueller-bmrn","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:18"],"evidence_ids":["alpha:projection-evidence:document:5f45c97dfae6a6e2383333577db0ddd9d1ab8eb5c78790fcf2c65bed5b404c65"],"summary":"Brian R. Mueller executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1e3v2prequzfb","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-21","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:c-greg-guyer-bmrn","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:19"],"evidence_ids":["alpha:projection-evidence:document:890d97ecd15c01311b5a4638e3242135244cb3d73e8b2179e02cd23655b0dc3c"],"summary":"C. Greg Guyer executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:qg9vqgzrrthu","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-21","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:cristin-hubbard-bmrn","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:20"],"evidence_ids":["alpha:projection-evidence:document:c94a9faf9269f87822325409f687ec8adbfc598b242875c9b808dadd22801e37"],"summary":"Cristin Hubbard executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1x57yp41tmi562","event_type":"GC_CHANGED","effective_at":"2026-04-21","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:george-s-davis","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:23"],"evidence_ids":["alpha:projection-evidence:document:3121c99406bd9128465de8ae6050939c26d7b39a2c5e0f37dff1514f939af504"],"summary":"George S. Davis executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:67rpxmwmies8","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-21","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:gregory-r-friberg-bmrn","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:24"],"evidence_ids":["alpha:projection-evidence:document:9b441dcc83b81cd5ab5d3f3cd2140e086e130c56013ce7d559e22b12e9cc046c"],"summary":"Gregory R. Friberg executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:yom8pw1xd3fru","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-04-21","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:rashmi-ramchandani","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:25"],"evidence_ids":["alpha:projection-evidence:document:a6d83333796563896596434ce13073426eff92b856543f6f9e372e576373949f"],"summary":"Rashmi Ramchandani executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:slmkwn8jbhyt","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:ian-t-clark","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b"],"summary":"Ian T. Clark seat on BIOMARIN PHARMACEUTICAL INC, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ysoj9fnvv9x5","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:timothy-p-walbert","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b"],"summary":"Timothy P. Walbert seat on BIOMARIN PHARMACEUTICAL INC, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1c7a4hbrcap0p","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:committee:biomarin-pharmaceutical-inc:compensation-nominating-and-governance","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b"],"summary":"Compensation; Nominating and Governance committee of BIOMARIN PHARMACEUTICAL INC, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1eoccuv19hibqf","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:timothy-p-walbert","alpha:committee:biomarin-pharmaceutical-inc:compensation-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b"],"summary":"Timothy P. Walbert member of Compensation; Nominating and Governance, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ytbvx6ylibus","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:alexander-hardy","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b"],"summary":"Adrian Hardy seat on BIOMARIN PHARMACEUTICAL INC, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ckheej16luhfp","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:athena-countouriotis","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b"],"summary":"Athena Countouriotis seat on BIOMARIN PHARMACEUTICAL INC, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:12gcmygwmc522","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:barbara-w-bodem","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b"],"summary":"Barbara W. Bodem seat on BIOMARIN PHARMACEUTICAL INC, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1k7gye81y4ax6","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:mark-enyedy","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b"],"summary":"Mark Enyedy seat on BIOMARIN PHARMACEUTICAL INC, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ioeli1bvnh7v","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:barbara-w-bodem","alpha:committee:biomarin-pharmaceutical-inc:audit"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_record:26"],"evidence_ids":["alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa"],"summary":"Barbara W. Bodem member of Audit, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:17z0sfp1hd8vej","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:maykin-ho","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b"],"summary":"Maykin Ho seat on BIOMARIN PHARMACEUTICAL INC, effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1kx7qpq1d1huza","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:elizabeth-mckee-anderson","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b"],"summary":"Elizabeth McKee Anderson seat on BIOMARIN PHARMACEUTICAL INC, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:hlb9wm2v5o9y","event_type":"COMMITTEE_CREATED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:committee:biomarin-pharmaceutical-inc:compensation-chair","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b"],"summary":"Compensation · Chair committee of BIOMARIN PHARMACEUTICAL INC, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:nhxmic1308wiq","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2019-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:elizabeth-mckee-anderson","alpha:committee:biomarin-pharmaceutical-inc:compensation-chair"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b"],"summary":"Elizabeth McKee Anderson member of Compensation · Chair, effective 2019-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:3u9xmj1rebxvn","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:robert-j-hombach","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b"],"summary":"Robert J. Hombach seat on BIOMARIN PHARMACEUTICAL INC, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:15daymd6mkw47","event_type":"COMMITTEE_CREATED","effective_at":"2017-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:committee:biomarin-pharmaceutical-inc:audit-chair","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b"],"summary":"Audit · Chair committee of BIOMARIN PHARMACEUTICAL INC, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:b1zd9q1lw987m","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2017-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:robert-j-hombach","alpha:committee:biomarin-pharmaceutical-inc:audit-chair"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b"],"summary":"Robert J. Hombach member of Audit · Chair, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1z0frgsxsnv38","event_type":"DIRECTOR_APPOINTED","effective_at":"2016-01-01","detected_at":"2026-10-17T04:45:33.016234+00:00","subject_ids":["alpha:person:willard-dere","alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8"],"caused_claim_ids":["alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:15"],"evidence_ids":["alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b"],"summary":"Willard Dere seat on BIOMARIN PHARMACEUTICAL INC, effective 2016-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:6","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:alexander-hardy","object_label":"Adrian Hardy","object_source_name_forms":[],"value":"Adrian Hardy: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:alexander-hardy","name":"Adrian Hardy"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BioMarin Pharmaceutical DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-07T00:23:06.905+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:7","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:athena-countouriotis","object_label":"Athena Countouriotis","object_source_name_forms":[],"value":"Athena Countouriotis: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:athena-countouriotis","name":"Athena Countouriotis"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BioMarin Pharmaceutical DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-07T00:23:06.905+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:8","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:barbara-w-bodem","object_label":"Barbara W. Bodem","object_source_name_forms":[],"value":"Barbara W. Bodem: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:barbara-w-bodem","name":"Barbara W. Bodem"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BioMarin Pharmaceutical DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-07T00:23:06.905+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:9","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:elizabeth-mckee-anderson","object_label":"Elizabeth McKee Anderson","object_source_name_forms":[],"value":"Elizabeth McKee Anderson: Director, Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:elizabeth-mckee-anderson","name":"Elizabeth McKee Anderson"},"title":"Director","role_category":"director","committee":"Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BioMarin Pharmaceutical DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-07T00:23:06.905+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:10","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ian-t-clark","object_label":"Ian T. Clark","object_source_name_forms":[],"value":"Ian T. Clark: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ian-t-clark","name":"Ian T. Clark"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BioMarin Pharmaceutical DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-07T00:23:06.905+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:11","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:mark-enyedy","object_label":"Mark Enyedy","object_source_name_forms":[],"value":"Mark Enyedy: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:mark-enyedy","name":"Mark Enyedy"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BioMarin Pharmaceutical DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-07T00:23:06.905+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:12","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:maykin-ho","object_label":"Maykin Ho","object_source_name_forms":[],"value":"Maykin Ho: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:maykin-ho","name":"Maykin Ho"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BioMarin Pharmaceutical DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-07T00:23:06.905+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:13","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:robert-j-hombach","object_label":"Robert J. Hombach","object_source_name_forms":[],"value":"Robert J. Hombach: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:robert-j-hombach","name":"Robert J. Hombach"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BioMarin Pharmaceutical DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-07T00:23:06.905+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:14","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:timothy-p-walbert","object_label":"Timothy P. Walbert","object_source_name_forms":[],"value":"Timothy P. Walbert: Director, Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:timothy-p-walbert","name":"Timothy P. Walbert"},"title":"Director","role_category":"director","committee":"Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BioMarin Pharmaceutical DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-07T00:23:06.905+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:15","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:willard-dere","object_label":"Willard Dere","object_source_name_forms":[],"value":"Willard Dere: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:willard-dere","name":"Willard Dere"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2016-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2016-01-01","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BioMarin Pharmaceutical DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-07T00:23:06.905+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21","effective_from":"2016-01-01","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:16","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:alexander-hardy","object_label":"Adrian Hardy","object_source_name_forms":[],"value":"Adrian Hardy: President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:alexander-hardy","name":"Adrian Hardy"},"title":"President and Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-21","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-21","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:b3598f3e6eda560d83a00f9929a83cc61bd68f09f96aa5c37d826e06902d6ccf","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BMRN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-07T00:24:55.923865+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21T00:00:00+00:00","effective_from":"2026-04-21","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:17","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:alexander-hardy-bmrn","object_label":"Alexander Hardy","object_source_name_forms":[],"value":"Alexander Hardy: President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:alexander-hardy-bmrn","name":"Alexander Hardy"},"title":"President and Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-21","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-21","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:b9594a4aa6be439b3adb396114e1a37caa813bbc904fc7cc39b1525322583957","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BMRN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-07T00:24:00.296384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21T00:00:00+00:00","effective_from":"2026-04-21","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:18","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:brian-r-mueller-bmrn","object_label":"Brian R. Mueller","object_source_name_forms":[],"value":"Brian R. Mueller: Executive Vice President and Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:brian-r-mueller-bmrn","name":"Brian R. Mueller"},"title":"Executive Vice President and Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-21","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-21","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:5f45c97dfae6a6e2383333577db0ddd9d1ab8eb5c78790fcf2c65bed5b404c65","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BMRN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-07T00:24:56.375969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21T00:00:00+00:00","effective_from":"2026-04-21","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:19","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:c-greg-guyer-bmrn","object_label":"C. Greg Guyer","object_source_name_forms":[],"value":"C. Greg Guyer: Executive Vice President and Chief Technical Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:c-greg-guyer-bmrn","name":"C. Greg Guyer"},"title":"Executive Vice President and Chief Technical Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-21","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-21","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:890d97ecd15c01311b5a4638e3242135244cb3d73e8b2179e02cd23655b0dc3c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BMRN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-07T00:24:57.735383+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21T00:00:00+00:00","effective_from":"2026-04-21","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:20","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:cristin-hubbard-bmrn","object_label":"Cristin Hubbard","object_source_name_forms":[],"value":"Cristin Hubbard: Executive Vice President and Chief Commercial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:cristin-hubbard-bmrn","name":"Cristin Hubbard"},"title":"Executive Vice President and Chief Commercial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-21","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-21","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:c94a9faf9269f87822325409f687ec8adbfc598b242875c9b808dadd22801e37","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BMRN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-07T00:24:58.192001+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21T00:00:00+00:00","effective_from":"2026-04-21","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:23","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:george-s-davis","object_label":"George S. Davis","object_source_name_forms":[],"value":"George S. Davis: Executive Vice President, Chief Legal Officer and Secretary","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:george-s-davis","name":"George S. Davis"},"title":"Executive Vice President, Chief Legal Officer and Secretary","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-21","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-21","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:3121c99406bd9128465de8ae6050939c26d7b39a2c5e0f37dff1514f939af504","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BMRN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-07T00:24:56.79187+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21T00:00:00+00:00","effective_from":"2026-04-21","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:24","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:gregory-r-friberg-bmrn","object_label":"Gregory R. Friberg","object_source_name_forms":[],"value":"Gregory R. Friberg: Executive Vice President and Chief Research Development Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:gregory-r-friberg-bmrn","name":"Gregory R. Friberg"},"title":"Executive Vice President and Chief Research Development Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-21","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-21","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:9b441dcc83b81cd5ab5d3f3cd2140e086e130c56013ce7d559e22b12e9cc046c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BMRN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-07T00:24:57.248009+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21T00:00:00+00:00","effective_from":"2026-04-21","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:25","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:rashmi-ramchandani","object_label":"Rashmi Ramchandani","object_source_name_forms":[],"value":"Rashmi Ramchandani: Vice President and Chief Accounting Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:rashmi-ramchandani","name":"Rashmi Ramchandani"},"title":"Vice President and Chief Accounting Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-21","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-21","valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:document:a6d83333796563896596434ce13073426eff92b856543f6f9e372e576373949f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BMRN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-07T00:24:58.653303+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-21T00:00:00+00:00","effective_from":"2026-04-21","effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_record:26","subject_id":"alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Robert J. Hombach; Members Robert J. Hombach (Chair); Barbara W. Bodem; Maykin Ho","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Robert J. Hombach","members":[{"display_name":"Robert J. Hombach","person_slug":"robert-j-hombach","is_chair":true},{"display_name":"Barbara W. Bodem","person_slug":"barbara-w-bodem","is_chair":false},{"display_name":"Maykin Ho","person_slug":"maykin-ho","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-17T04:45:33.016234+00:00","sources":[{"id":"alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"BioMarin Pharmaceutical DEF 14A 2026-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21","retrieved_at":"2026-05-07T00:23:06.905+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:b3598f3e6eda560d83a00f9929a83cc61bd68f09f96aa5c37d826e06902d6ccf","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BMRN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-07T00:24:55.923865+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:b9594a4aa6be439b3adb396114e1a37caa813bbc904fc7cc39b1525322583957","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BMRN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-07T00:24:00.296384+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:5f45c97dfae6a6e2383333577db0ddd9d1ab8eb5c78790fcf2c65bed5b404c65","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BMRN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-07T00:24:56.375969+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:890d97ecd15c01311b5a4638e3242135244cb3d73e8b2179e02cd23655b0dc3c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BMRN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-07T00:24:57.735383+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:c94a9faf9269f87822325409f687ec8adbfc598b242875c9b808dadd22801e37","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BMRN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-07T00:24:58.192001+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:3121c99406bd9128465de8ae6050939c26d7b39a2c5e0f37dff1514f939af504","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BMRN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-07T00:24:56.79187+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:9b441dcc83b81cd5ab5d3f3cd2140e086e130c56013ce7d559e22b12e9cc046c","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BMRN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-07T00:24:57.248009+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:a6d83333796563896596434ce13073426eff92b856543f6f9e372e576373949f","identity_scope":"source_document_reference","source_type":"sec_filing","title":"BMRN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":"2026-04-21T00:00:00+00:00","retrieved_at":"2026-05-07T00:24:58.653303+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.838,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.861,"cross_source_agreement":0.75,"temporal_completeness":0.667},"diagnostics":{"published_claims":35,"factual_claims":35,"claims_with_linked_evidence":35,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":27,"temporal_claims_with_valid_from":18,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-17T04:45:33.016234+00:00","observed_at":"2026-10-17T04:45:33.016234+00:00","reviewed_at":"2026-10-17T04:45:33.016234+00:00","verified_at":"2026-10-17T04:45:33.016234+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":35,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/biomarin-pharmaceutical-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}